Analysis of responses to angiotensin I-(3-10) in the hindlimb vascular bed of the cat

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 4 39-4, 1996, Pages

  Garrison, Etoi A ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin converting enzyme; angiotensin IV; angiotensin type 1 receptors; peripheral vascular bed; vasoconstrictor responses

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 4 PENTAFLUOROETHYL 2 PROPYL 1 [[2' (1H TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN II [3-8]; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CAT; CONTROLLED STUDY; DOSE RESPONSE; HINDLIMB; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PERFUSION PRESSURE; PRESSOR RESPONSE; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0029866262     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.4.h1172     Document Type: Article

References (38)

1. Ahmad, S., and P. E. Ward. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J. Pharmacol Exp. Ther. 252: 643-650, 1990.
2. Benter, I. F., D. I. Diz, and C. M. Ferrario. Cardiovascular actions of angiotensin(1-7). Peptides 14: 679-684, 1993.
3. Bernier, S. G., A. Fournier, and G. Guillemette. A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes. Eur: J. Pharmacol. 271: 55-63, 1994.
4. Blair-West, J. R., J. P. Coghlan, D. A. Denton, J. W. Fundes, B. A. Scoggins, and R. D. Wright. The effect of the heptapeptide (2-8) and hexapeptide (3-8) fragments of angiotensin II or aldosterone secretion. J. Clin. Endocrinol. Metab. 32. 575-578, 1971.
5. 2 subtype. J. Med. Chem. 34: 3248-3260, 1991.
6. Chappell, M. C., K. B. Brosnihan, D. I. Diz, and C. M. Ferrario. Identification of angiotensin-(l-71 in rat brain: evidence for differential processing of angiotensin peptides. J. Biol. Chem. 264: 16518-16523, 1989.
7. Chappell, M. C., K. B. Brosnihan, W. R. Welches, and C. M. Ferrario. Characterization by high performance liquid chromatography of angiotensin peptides in the plasma and cerebrospinal fluid of the dog. Peptides 8: 939-942, 1987.
8. Cheng, D. Y., B. J. DeWitt, E. L. Dent, B. D. Nossaman, and P. J. Kadowitz. Analysis of responses to angiotensin IV in the pulmonary vascular bed of the cat. Eur. J. Pharmacol. 261: 223-227, 1994.
9. Coleman, J. K. M., L. Keebs, B. Ong, J. M. Hanesworth, K. A. Lawrence, M. Sardinia, J. W. Harding, and J. W. Wright. Changes in renal blood flow due to intra-arterial infusions of angiotensin II (3-8) [AIV] and AIV analogs (Abstract). FASEB J. 7: A437, 1993.
10. 6 Angll, on thirst and sodium appetite in rats. Exp. Physiol. 78: 767-774, 1993.
11. Fleming, J. T., G. L. Anderson, and J. Chen. Skeletal muscle arteriolar constriction to ANG II evaluation of a myogenic component. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1847-H1854, 1992.
12. Fleming, J. T., and I. G. Joshua. Mechanism of the biphasic arteriolar response to angiotensin II. Am, J. Physiol. 247 (Heart Circ. Physiol. 16): H88-H99, 1989.
13. Gardiner, S. M., P. A. Kemp, J. E. March, and T. Bennett. Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. J. Pharmacol. 110: 159-162, 1993.
14. Garrison, E. A., J. A. Santiago, S. Y. Osei, and P. J. Kadowitz. Analysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2418-H2424, 1995.
15. Haberl, R. L., P. J. Decker, and K, M. Einhaupl. Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ. Res. 68: 1621-1627, 1991.
16. Hall, K. L., J. M. Hanesworth, A. E. Ball, G. P. Felgenhauer, H. L. Hosick, and J. W. Harding. Identification and characterization of a novel binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul. Pept. 44: 225-232, 1993.
17. Hanesworth, J. M., M. F. Sardinia, L. T. Krebs, K. L. Hall, and J. W. Harding. Elucidation of a specific binding site for angiotensin II (3-8). angiotensin IV, in mammalian heart membranes. J. Pharmacol. Exp. Ther. 266: 1036-1042, 1993.
18. Harding, J. W., V. I. Cook, A. V. Miller-Wing, J. M. Hanesworth, M. F. Sardinia, K. L. Hall, J. W. Stobb, G. N. Swanson, J. K. M. Coleman, J. W. Wright, and E. C. Harding. Identification of an AIK(3-8) [AIVJ binding site in guinea pig hippocampus. Brain Res. 583: 340-343. 1992.
19. 2 recognition sites in bovine adrenal cortex. Eur. J. Pharmacol. 219: 319-322, 1992.
20. Johnson, H., and O. H. Drummer. Hydrolysis of angiotensin I by peptidases in homogenstes of rat lung and aorta. Biochem. Pharmacol. 37: 1131-1136, 1988.
21. 2 subtype-specific angiotensin II ligands. J. Pharmacol. Exp. Ther. 262: 1154-1160, 1992.
22. Kohara, K., K. B. Brosnihan, M. C. Chappell, M. C. Khosla, and C. M. Ferrario. Angiotensin-(l-7): a member of circulating angiotensin peptides. Hypertension Dallas 17: 131-138, 1991.
23. Kohara, K., K, B. Brosnihan, and C. M. Ferrario. Angiotensin(l-7) in the spontaneously hypertensive rat. Peptides 14: 883-891, 1993.
24. Kohara, K., Y. Tabuchi, P. Senanayake, K. B. Brosnihan, and C. M. Ferrario. Reassessment of plasma angiotensins measurement; effects of protease inhibitors and sample handling procedures. Peptides 12: 1135-1141, 1991.
25. 2angiotensin II in man. Acta Endocrinol. 99: 577-589, 1982.
26. Kono, T., F. Ikeda, A. Taniguchi, H. Imura, F. Osekio, M. Yoshioka, and M. C. Khosla. Responses of patients with Bartter's syndrome to angiotensin III and the angiotensin II(3-8) hexapeptide. Acta Endocrinol. 109: 240-253, 1985.
27. McDonald, J. T., and C. H. Schwabe. Intracellular exopeptidases. In: Proteases in Mammalian Cells and Tissues, edited by A. J. Barrett. New York: North-Holland, 1977, p. 311-318.
28. Oparil, S., T. Koerner, G. W. Tregear, B. A. Barnes, and E. Haber. Substrate requirements for angiotensin I conversion in vivo and in vitro. Circ. Res. 32: 415-422, 1973.
29. Osei, S. Y., R. K. Minkes, J. A. Bellan, and P. J. Kadowitz. Analysis of inhibitory effects of DuP 753 and Exp 3174 on the responses to angiotensin II in the feline hindquarter beds. J. Pharmacol. Exp. Ther. 264: 1104-1111, 1993.
30. Pörsti, I., A. T. Bara, R. Busse, and M. Hecker. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br. J. Pharmacol. 111: 652-654, 1994.
31. 4 receptor binding characteristics: D-amino acidand glycine-substituted peptides. Peptides 14: 949-954, 1993.
32. 4 receptor structure-binding relationship: Nterminal-modified angiotensin IV analogues. Peptides 15: 1399-1406, 1994.
33. Scheuer, D. A., and M. H. Perrone. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R917-R923, 1993.
34. Semple, P. F., A. S. Boyd, P. M. Dawes, and J. M. Morton. Angiotensin II and its heptapeptide (2-8), hexapeptide (3-8) and pentapeptide (4-8) metabolites in arterial and venous blood of man. Circ. Res. 39: 671-678, 1976
35. Snedecor, G. W., and W. G. Cochran. Statistical Methods (7th ed.). Ames: Iowa State Univ. Press, 1968.
36. Swanson, G. N., J. M. Hanesworth, M. F. Sardinia, J. K. M. Coleman, J. W. Wright, K. L. Hall, A. V. Miller-Wing, J. W. Stobb, V. I. Cook, E. C. Harding, and J. W. Harding. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul. Pept. 40: 409-419, 1992.
37. Vicaut, E., and X. Hou. Arteriolar constriction and local renin angiotensin system in the rat microcirculation. Hypertension Dallas 21: 491-497, 1993.
38. Ward, P. E. Immunoelectrophoretic analysis of vascular membrane-bound angiotensin I converting enzyme, aminopeptidase M, and dipeptidyl (amino) peptidase IV. Biochem. Pharmacol. 33: 3183-3193, 1984.